24 min
ENDRA Life Sciences, Inc. (NDRA) Francois Michelon, CEO The Wall Street Resource
-
- Investing
The pioneer of Thermo Acoustic Enhanced
UltraSound (TAEUS®), a
ground-breaking technology which characterizes tissue similar to an MRI, but at
1/50th the cost
and at the point of patient care. TAEUS® is designed to work in concert with the more than 700,000
ultrasound systems in use globally today. TAEUS® is initially focused on the measurement
of fat in the liver as a means to assess and monitor steatotic liver disease
(SLD) (formerly known as NAFLD-NASH), a chronic liver disease spectrum that
affects over two billion people globally, and for which there are no practical
diagnostic tools. Beyond the liver, ENDRA is exploring several other clinical
applications of TAEUS®, including
visualization of tissue temperature during energy-based surgical procedures.
The pioneer of Thermo Acoustic Enhanced
UltraSound (TAEUS®), a
ground-breaking technology which characterizes tissue similar to an MRI, but at
1/50th the cost
and at the point of patient care. TAEUS® is designed to work in concert with the more than 700,000
ultrasound systems in use globally today. TAEUS® is initially focused on the measurement
of fat in the liver as a means to assess and monitor steatotic liver disease
(SLD) (formerly known as NAFLD-NASH), a chronic liver disease spectrum that
affects over two billion people globally, and for which there are no practical
diagnostic tools. Beyond the liver, ENDRA is exploring several other clinical
applications of TAEUS®, including
visualization of tissue temperature during energy-based surgical procedures.
24 min